| NCT ID | NCT07140731 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Jacobs institute |
| Condition | Moyamoya Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 15 participants |
| Start Date | 2025-09-20 |
| Primary Completion | 2027-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 15 participants in total. It began in 2025-09-20 with a primary completion date of 2027-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A research study for a neurosurgical procedure in adult patients with Moyamoya disease
Eligibility Criteria
Inclusion Criteria: 1. Patients aged \>18. 2. Moyamoya disease with minor to moderate symptoms requiring neurosurgical treatment. 3. Patients agree to have the surgery and the anesthesia. 4. Patients who voluntarily decide to participate in this study with the surgery performed with the aid of Symani and agree to sign the Informed Consent Form. \- Exclusion Criteria: 1. Patients who have bleeding or coagulation disorders in the past or present. 2. Any criteria that preclude prolonged anesthesia. 3. Hemodynamically unstable neurological exam. 4. Pressure dependent neurologic status.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07140731 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Moyamoya Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07140731 currently recruiting?
Yes, NCT07140731 is actively recruiting participants. Contact the research team at cpena@jacobsinstitute.org for enrollment information.
Where is the NCT07140731 trial being conducted?
This trial is being conducted at Buffalo, United States.
Who is sponsoring the NCT07140731 clinical trial?
NCT07140731 is sponsored by Jacobs institute. The trial plans to enroll 15 participants.